AMENDMENT NO. 1 TO SERIES B WARRANTSeries B Warrant Amendment • May 29th, 2015 • Capstone Financial Group, Inc. • Finance services
This Amendment No. 1 to Series B Warrant (“Amendment No. 1”) is made and entered into as of May 28, 2015 (the “Effective Date”) by and between Twinlab Consolidated Holdings, Inc. (“TCH” or the “Company”), a Nevada corporation, and Capstone Financial Group, Inc., a Nevada corporation (“Capstone” or “Registered Owner”).
AMENDMENT NO. 1 TO THE SERIES B WARRANT TO PURCHASE COMMON STOCKSeries B Warrant Amendment • September 13th, 2021 • Sierra Oncology, Inc. • Pharmaceutical preparations • New York
This Amendment No. 1 to the Series B Warrant to Purchase Common Stock dated September 8, 2021 is made effective as of September 8, 2021 (the “Amendment”), by and among Sierra Oncology, Inc., a Delaware corporation (the “Company”), and [ ] (the “Investor” and together with the Company, the “Parties”).
AMENDMENT TO SERIES B WARRANT TO PURCHASE SHARES OF COMMON STOCK OF BPO MANAGEMENT SERVICES, INC.Series B Warrant Amendment • April 28th, 2008 • BPO Management Services • Services-prepackaged software
This Amendment to Series B Warrant to Purchase Shares of Common Stock of BPO Management Services, Inc. (this “Amendment”) is effective as of April 18, 2008, by BPO Management Services, Inc., a Delaware corporation (“Issuer”), in favor of __________________ (“Holder”). Issuer and Holder are, together, the “Parties.”
WEIL:\98834688\2\11008.0003 THIRD AMENDMENT TO SERIES B WARRANT TO PURCHASE COMMON STOCK This THIRD AMENDMENT TO SERIES B WARRANT TO PURCHASE COMMON STOCK, dated as of September 30, 2022 (this “Amendment”), is made by and between Acacia Research...Series B Warrant Amendment • September 30th, 2022 • Acacia Research Corp • Patent owners & lessors
Amendment No. 1 to Series B Warrant to Purchase Common StockSeries B Warrant Amendment • May 11th, 2021 • CBAK Energy Technology, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
AMENDMENT NO. 1 TO SERIES B WARRANT TO PURCHASE COMMON STOCK (“Amendment”) is made as of the ___ day of May, 2021 by and between CBAK Energy Technology, Inc., a Nevada corporation (the “Company”) and the holder listed on the signature page attached hereto (the “Holder”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Warrant (as defined below).
AMENDMENT NO. 1 TO SERIES B WARRANTSeries B Warrant Amendment • June 3rd, 2015 • Twinlab Consolidated Holdings, Inc. • Medicinal chemicals & botanical products
This Amendment No. 1 to Series B Warrant (“Amendment No. 1”) is made and entered into as of May 28, 2015 (the “Effective Date”) by and between Twinlab Consolidated Holdings, Inc. (“TCH” or the “Company”), a Nevada corporation, and Capstone Financial Group, Inc., a Nevada corporation (“Capstone” or “Registered Owner”).
FIRST AMENDMENT TO SERIES B WARRANT TO PURCHASE SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK OF NASCENT WINE COMPANY, INC.Series B Warrant Amendment • October 26th, 2007 • Nascent Wine Company, Inc. • Wholesale-beer, wine & distilled alcoholic beverages
FIRST AMENDMENT TO SERIES B WARRANT TO PURCHASE SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK OF NASCENT WINE COMPANY, INC. dated as of October 22, 2007 (this “Amendment”), by and among Nascent Wine Company, a Nevada corporation (the “Issuer”), and the holders of the Original Warrants (as defined below) identified on the signature page hereto (each, a “Holder” and collectively, the “Holders”).
SERIES B WARRANT AMENDMENTSeries B Warrant Amendment • May 17th, 2024 • Volcon, Inc. • Motor vehicles & passenger car bodies • New York
This Series B Warrant Amendment dated as of May 17, 2024 (the “Amendment”) is by and between Volcon, Inc., a Delaware corporation (the “Company”), and the undersigned, a Holder of Series B Warrants issued on November 17, 2023 (the “Warrants”).
ROSETTA GENOMICS LTD. AMENDMENT TO SERIES B WARRANT TO PURCHASE ORDINARY SHARESSeries B Warrant Amendment • December 3rd, 2015 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Amendment (this “Amendment”) to each Series B Warrant (each a “Series B Warrant,” and collectively the “Series B Warrants”) issued pursuant to that certain Securities Purchase Agreement, dated as of October 13, 2015, by and among Rosetta Genomics Ltd., a company organized under the laws of the State of Israel, and the Purchasers referred to therein (the “Purchase Agreement”), shall be effective as of the date that this Amendment is executed by the Company and the holders of Series B Warrants constituting the Required Holders. Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the Purchase Agreement.
